drugset / Trial / NCT00143676
Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the efficacy of lapaquistat acetate, once daily (QD), on lowering cholesterol in subjects already taking atorvastatin.
Timeline
- Start
- 2005-08
- Primary completion
- 2006-08
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lapaquistat acetate | Small molecule | 50 mg | Oral |
| Subject | Lapaquistat acetate | Small molecule | 100 mg | Oral |
| Comparator | Atorvastatin | Small molecule | — | Oral |